DNA Repeat Length in Murine Bone Marrow and L1210 Leukaemia Cells
Author Information
Author(s): S.W. Dean, K.D. Tew, A.E. Clark, P.S. Schein
Primary Institution: Lombardi Cancer Center, Georgetown University
Hypothesis
The study investigates the differential binding of nitrosoureas to chromatin in murine bone marrow and L1210 leukaemia cells based on DNA repeat and linker lengths.
Conclusion
The study found that the DNA linker length in murine bone marrow is approximately 22% longer than in L1210 leukaemia cells, but this difference does not fully explain the selective toxicity of sugar nitrosoureas.
Supporting Evidence
- The linker length of bone marrow chromatin was approximately 22% longer than that in L1210 leukaemia cells.
- The study observed small differences in linker length, though insufficient to account entirely for the previously reported differences in drug binding.
- More marrow-toxic CCNU binds to the nucleosomal DNA in both cell types and less to the linker DNA.
Takeaway
The DNA in bone marrow cells is a bit longer than in leukaemia cells, but this doesn't completely explain why some cancer drugs are less harmful to bone marrow.
Methodology
The study measured DNA repeat and linker lengths using electrophoresis of micrococcal nuclease-digested DNA from murine bone marrow and L1210 leukaemia cells.
Limitations
The differences in DNA linker length observed were insufficient to account entirely for the differences in drug binding.
Participant Demographics
The study involved murine bone marrow and L1210 leukaemia cells.
Want to read the original?
Access the complete publication on the publisher's website